Maridea Wealth Management’s ResMed RMD Stock Holding History

Maridea Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,569	Closed	-$378K	–	499
2025 Q4	$378K	Buy	+1,569	New	+$401K	0.06%	300
2025 Q3	–	Sell	-1,243	Closed	-$321K	–	447
2025 Q2	$321K	Sell	1,243 -215	-15%	-$51.3K	0.08%	211
2025 Q1	$326K	Sell	1,458 -647	-31%	-$151K	0.11%	174
2024 Q4	$481K	Buy	+2,105	New	+$507K	0.16%	115

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Maridea Wealth Management's RMD Position: Q1 2026 in Review

Maridea Wealth Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,569 shares — an estimated $378K sold.

Maridea Wealth Management first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $481K in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Maridea Wealth Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Maridea Wealth Management sold 1,569 ResMed shares in Q1 2026, an estimated $378K.
Maridea Wealth Management first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
Maridea Wealth Management's ResMed position peaked at $481K in Q4 2024.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Maridea Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.